eFFECTOR Therapeutics to Present at JMP Securities 2021 Life Sciences Conference

NEXT STORY
Global Antibiotics Market to Exceed $58,798.1 Million at a CAGR of 4.0% from 2020 to 2027 – Exclusive Report [234 Pages] By Research Dive
PREV STORY
Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trials for STI-2020 (COVI-AMG) in Healthy Volunteers and in Newly Diagnosed COVID-19 Patients

author_avatar
NASDAQ Market News

Recro Pharma Reports Second Quarter 2018 Financial Results

Company to Host Conference Call Today at 8:00 AM ETMALVERN, Pa., Aug. 07, 2018 ...

author_avatar
NASDAQ Market News

Darolutamide submitted for marketing authorization in Japan

author_avatar
NASDAQ Market News